Krajewska Barbara, Zaborska Wiesława
Faculty of Chemistry, Jagiellonian University, Ingardena 3, 30-060 Kraków, Poland.
Bioorg Chem. 2007 Oct;35(5):355-65. doi: 10.1016/j.bioorg.2007.02.002. Epub 2007 Apr 6.
In view of the complexity of the role of the active site flap cysteine in the urease catalysis, in this work we studied how the presence of typical active-site binding inhibitors of urease, phenylphosphorodiamidate (PPD), acetohydroxamic acid (AHA), boric acid and fluoride, affects the reactivity of enzyme thiol groups, the active site flap thiol in particular. For that the inhibitor-urease complexes were prepared with excess inhibitors and had their thiol groups titrated with DTNB. The effects observed were analyzed in terms of the structures of the inhibitor-urease complexes reported in the literature. We found that the effectiveness in preventing the active site cysteine from the modification by disulfides, varied among the inhibitors studied, even though they all bind to the active site. The variations were accounted for by different extents of geometrical distortion in the active site that the inhibitors introduced upon binding, leaving the flap either open in AHA-, boric acid- and fluoride-inhibited urease, like in the native enzyme or closed in PPD-inhibited urease. Among the inhibitors, only PPD was found to be able to thoroughly protect the flap cysteines from the further reaction with disulfides, this apparently resulting from the closed conformation of the flap. Accordingly, in practical terms PPD may be regarded as the most suitable inhibitor for active-site protection experiments in inhibition studies of urease.
鉴于活性位点瓣半胱氨酸在脲酶催化作用中的角色复杂,在本研究中,我们探究了脲酶典型活性位点结合抑制剂苯膦二酰胺(PPD)、乙酰氧肟酸(AHA)、硼酸和氟化物的存在如何影响酶硫醇基团的反应活性,尤其是活性位点瓣硫醇的反应活性。为此,用过量抑制剂制备了抑制剂 - 脲酶复合物,并用5,5'-二硫代双(2-硝基苯甲酸)(DTNB)对其硫醇基团进行滴定。根据文献报道的抑制剂 - 脲酶复合物结构分析观察到的效应。我们发现,在所研究的抑制剂中,尽管它们都与活性位点结合,但在防止活性位点半胱氨酸被二硫化物修饰方面的有效性各不相同。这些差异是由抑制剂结合时在活性位点引入的不同程度的几何畸变所导致的,使得在AHA、硼酸和氟化物抑制的脲酶中,瓣像天然酶一样处于开放状态,而在PPD抑制的脲酶中瓣处于关闭状态。在这些抑制剂中,仅发现PPD能够彻底保护瓣半胱氨酸不与二硫化物进一步反应,这显然是由于瓣的关闭构象所致。因此,实际上在脲酶抑制研究中,PPD可被视为活性位点保护实验最合适的抑制剂。